Are anti-vascular endothelial growth factor drugs the panacea for all diabetic retinopathy patients?

Bibliographic Details
Main Author: Jacob Koshy
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2013-01-01
Series:Journal of Clinical Ophthalmology and Research
Online Access:http://www.jcor.in/article.asp?issn=2320-3897;year=2013;volume=1;issue=2;spage=123;epage=123;aulast=Koshy
id doaj-f220e263e0594f96be8ca78d7a2447e3
record_format Article
spelling doaj-f220e263e0594f96be8ca78d7a2447e32020-11-24T20:43:41ZengWolters Kluwer Medknow PublicationsJournal of Clinical Ophthalmology and Research2320-38972013-01-011212312310.4103/2320-3897.112183Are anti-vascular endothelial growth factor drugs the panacea for all diabetic retinopathy patients?Jacob Koshyhttp://www.jcor.in/article.asp?issn=2320-3897;year=2013;volume=1;issue=2;spage=123;epage=123;aulast=Koshy
collection DOAJ
language English
format Article
sources DOAJ
author Jacob Koshy
spellingShingle Jacob Koshy
Are anti-vascular endothelial growth factor drugs the panacea for all diabetic retinopathy patients?
Journal of Clinical Ophthalmology and Research
author_facet Jacob Koshy
author_sort Jacob Koshy
title Are anti-vascular endothelial growth factor drugs the panacea for all diabetic retinopathy patients?
title_short Are anti-vascular endothelial growth factor drugs the panacea for all diabetic retinopathy patients?
title_full Are anti-vascular endothelial growth factor drugs the panacea for all diabetic retinopathy patients?
title_fullStr Are anti-vascular endothelial growth factor drugs the panacea for all diabetic retinopathy patients?
title_full_unstemmed Are anti-vascular endothelial growth factor drugs the panacea for all diabetic retinopathy patients?
title_sort are anti-vascular endothelial growth factor drugs the panacea for all diabetic retinopathy patients?
publisher Wolters Kluwer Medknow Publications
series Journal of Clinical Ophthalmology and Research
issn 2320-3897
publishDate 2013-01-01
url http://www.jcor.in/article.asp?issn=2320-3897;year=2013;volume=1;issue=2;spage=123;epage=123;aulast=Koshy
work_keys_str_mv AT jacobkoshy areantivascularendothelialgrowthfactordrugsthepanaceaforalldiabeticretinopathypatients
_version_ 1716819116484984832